Derniers articles listés par NCBI PubMed sur les maladies inflammatoires du foie et des voies biliaires (en anglais)
Qu’est-ce que PubMed?
Pubmed est la Bibliothèque Nationale de Médecine américaine. Pubmed incorpore plus de 24 millions d’extraits de littérature biomédicale issus du service en ligne MEDLINE, de journaux et livres scientifiques. Les extraits incorporent parfois des liens vers les textes intégraux des articles ou vers les sites web des éditeurs. Ces documents sont des publications scientifiques relatant l’avancée de la recherche sur les maladies inflammatoires du foie et des voies biliaires. Ils sont relayés ici sur le site d’albi afin que les malades comme les professionnels de la santé se fassent une idée des thématiques d’études et des avancées de la recherche. Il faut bien comprendre que ces communications sont des résultats de recherches ponctuelles, qui doivent être validés par d’autres études, pour éventuellement déboucher sur des innovations thérapeutiques quelques années plus tard. Si vous êtes malade, il est évident que ces informations ne peuvent pas être prises en compte pour prendre l’initiative d’une quelconque modification de votre traitement, modification qui ne peut se faire que sous avis médical.
> création: PhDu, albi, le 15/10/2013
> rédaction: PhDu, albi, le 15/10/2013
What is PubMed?
PubMed is the US National Library of Medicine. PubMed comprises more than 24 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
pubmed
- Reply - Associations between drug exposure and outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease.
- Whole-Liver Apparent Diffusion Coefficient Histogram Analysis for the Diagnosis and Staging of Liver Fibrosis.
- Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
- Distinct Disease Phenotype of Ulcerative Colitis in Patients With Coincident Primary Sclerosing Cholangitis: Evidence From a Large Retrospective Study With Matched Cohorts.
- Similarities and differences in clinical and pathologic features of inflammatory bowel disease-associated colorectal cancer in China and Canada.
- Clinical utility of FibroScan as a non-invasive diagnostic test for primary biliary cholangitis.
- Autoimmune hepatitis induction can occur in the liver.
- Unusual intestinal and extra intestinal findings in Crohn's disease seen on abdominal computed tomography and magnetic resonance enterography.
- Rapid Response to Treatment of Autoimmune Hepatitis Associated with Remission at 6 and 12 Months.
- Evaluation of the primary biliary cholangitis-related serologic profile in a large cohort of Belgian systemic sclerosis patients.
- Clinical Management of Primary Biliary Cholangitis-Strategies and Evolving Trends.
- Peribiliary glands: development, dysfunction, related conditions and imaging findings.
- A Prospective Trial of Withdrawal and Reinstitution of Ursodeoxycholic Acid in Pediatric Primary Sclerosing Cholangitis.
- Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome.
- Clinical management of autoimmune hepatitis.
- A Cautionary Report of Doxycycline-induced Autoimmune Hepatitis.
- No difference in TCRβ repertoire of CD4+ naive T cell between patients with primary biliary cholangitis and healthy control subjects.
- Protein abundance of hepatic drug transporters in patients with different forms of liver damage.
- A Novel Phosphoinositide-3-kinase Adapter Protein 1 Gene Missense Mutation in Familial Cirrhosis.
- Is It Safe to Perform Endoscopic Retrograde Cholangiopancreatography in Decompensated Cirrhosis?
- Increasing Prevalence of Primary Biliary Cholangitis in Victoria, Australia.
- Sex differences in clinical presentation and prognosis in patients with primary biliary cholangitis.
- [Autoimmune hepatitis and pregnancy: a case series].
- [Portal vein thrombosis in patients undergoing to liver transplantation].
- Changes in the distribution of etiologies of cirrhosis among patients referred for liver transplantation over 11 years in Iran.
- TNF-Producing Th1 Cells Are Selectively Expanded in Liver Infiltrates of Patients with Autoimmune Hepatitis.
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
- IgM response is a prognostic biomarker of primary biliary cholangitis treated with ursodeoxycholic acid and bezafibrate.
- Changes in Liver Stiffness, Measured by Magnetic Resonance Elastography, Associated With Hepatic Decompensation in Patients With Primary Sclerosing Cholangitis.
- Methylprednisolone Decreases Mitochondria-Mediated Apoptosis and Autophagy Dysfunction in Hepatocytes of Experimental Autoimmune Hepatitis Model via the Akt/mTOR Signaling.
- Liver Injury in Patients with Cholestatic Liver Disease Treated with Obeticholic Acid.
- Something old, something new: liver injury associated with Total parenteral nutrition therapy and immune checkpoint inhibitors.
- The MHC II-CD4 Immunologic Synapse in Alcoholic Hepatitis and Autoimmune Liver Pathology: The Role of Aberrant MHC II in Hepatocytes.
- Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression.
- Safety of Combination Biologic and Antirejection Therapy Post-Liver Transplantation in Patients With Inflammatory Bowel Disease.
- PBC-10: a short quality of life measure for clinical screening in primary biliary cholangitis.
- Prognostic Value of Noninvasive Fibrosis Scores in Primary Biliary Cholangitis.
- The transcription factor ETS1 promotes apoptosis resistance of senescent cholangiocytes by epigenetically up-regulating the apoptosis suppressor BCL2L1.
- Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience.
- Gut mycobiome of primary sclerosing cholangitis patients is characterised by an increase of Trichocladium griseum and Candida species.
- Wilson's disease presentation resembling autoimmune hepatitis.
- Prognostic significance of serum tyrosine concentration in patients with primary biliary cholangitis under ursodeoxycholic acid therapy.
- Assessing the Validity of Adult-Derived Prognostic Models for Primary Sclerosing Cholangitis Outcomes in Children.
- Increased Posttransplant Mortality for Autoimmune Hepatitis Compared With Other Autoimmune Liver Diseases.
- Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis.
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
- Bile acids and bilirubin effects on osteoblastic gene profile. Implications in the pathogenesis of osteoporosis in liver diseases.
- Identification of Marker Genes and Pathways in Patients with Primary Biliary Cholangitis.
- The JAK inhibitor tofacitinib ameliorates immune‑mediated liver injury in mice.
- Acute Liver Injury in a Patient Treated With Rosuvastatin: A Rare Adverse Effect.
- Hypercholesterolemia Due to Lipoprotein X: Case Report and Thematic Review.
- Finger clubbing and cirrhosis in a sarcoidosis patient.
- Letter to the Editor: Bone health and denosumab treatment in autoimmune liver diseases: a possible involvement of physical activity.
- Reply to Letter to the Editor (HEP-19-1638).
- The relative expression of hepatocellular and cholestatic liver enzymes in adult patients with liver disease.
- Chronic hepatitis associated with antiribosomal-P autoantibodies in a 14-year-old girl.
- Exploration the significance of Tfh and related molecules on C57BL/6 mice model of experimental autoimmune hepatitis.
- Permanent immunosuppression in SLA/LP-positive autoimmune hepatitis is required although overall response and survival are similar.
- Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience.
- Is Ulcerative Colitis Associated With Primary Sclerosing Cholangitis an Undertreated Condition?
- Imaging Features of Primary Sclerosing Cholangitis: From Diagnosis to Liver Transplant Follow-up.
- Autoimmune conditions and primary central nervous system lymphoma risk among older adults.
- Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response.
- Severe Primary Sclerosing Cholangitis Biliary Stricture Managed With a Small-Caliber Cardiac Angioplasty Balloon: Looking Outside the Endoscopic Retrograde Cholangiopancreatography Toolbox.
- Adverse events related to low dose corticosteroids in autoimmune hepatitis.
- Histopathological Features of Drug-Induced Liver Injury Secondary to Osimertinib.
- Novel Diagnostic and Therapeutic Strategies in Juvenile Autoimmune Hepatitis.
- A case of melatonin-induced biochemical flare in a patient with primary sclerosing cholangitis with features of autoimmune hepatitis.
- Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence.
- A Mechanistic Insight Into The Role Of Gut Microbiota In The Pathogenesis Of Primary Sclerosing Cholangitis.
- Changing etiologies and prognostic factors in pediatric acute liver failure.
- Long-term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis.
- Hepatic expression of programmed death-1 (PD-1) and its ligand, PD-L1, in children with autoimmune hepatitis: relation to treatment response.
- Transient elastography reliably estimates liver fibrosis in autoimmune hepatitis.
- [Advances in the study of abnormal expression of genes related to primary biliary cholangitis].
- [Situational analysis of clinical application of diagnostic scoring system for autoimmune hepatitis].
- [Situation analysis of timing of first visit of anti-mitochondrial antibody-positive patients].
- Establishing Reliability Criteria for Liver ElastPQ Shear Wave Elastography (ElastPQ-SWE): Comparison Between 10, 5 and 3 Measurements.
- Associations between drug exposure and outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease.
- Challenges in the use of corticosteroids in the management of autoimmune hepatitis.
- Continuing Medical Education Questions: October 2019.
- Incidence, Risk Factors, and Follow-Up of Diabetes Mellitus After Liver Transplant: A Prospective Study From Iran.
- Rare but heard: using asynchronous virtual focus groups, interviews and roundtable discussions to create a personalised psychological intervention for primary sclerosing cholangitis: a protocol.
- Contributing awareness of autoimmune hepatitis in HIV patients.
- Erosive pustular dermatosis of the scalp: challenges and solutions.
- Cholangioscopy Biopsies Improve Detection of Cholangiocarcinoma When Combined with Cytology and FISH, but Not in Patients with PSC.
- No association of HLA-DRB1 and TNF alleles in Mexican patients with autoimmune hepatitis.
- Potential Association of Doxycycline With the Onset of Primary Sclerosing Cholangitis: A Case Series.
- Menotrophin Induced Autoimmune Hepatitis.
- "Let my liver rather heat with wine" - a review of hepatic fibrosis pathophysiology and emerging therapeutics.
- Gut and oral microbiota in autoimmune liver disease.
- Rate of non-response to ursodeoxycholic acid in a large real-world cohort of primary biliary cholangitis patients in Italy.
- Regulatory interaction between the ZPBP2-ORMDL3/Zpbp2-Ormdl3 region and the circadian clock.
- Fatty Liver and Autoimmune Hepatitis: Two Forms of Liver Involvement in Lipodystrophies.
- Autoimmune hepatitis in human immunodeficiency virus-infected patients: A case series and review of the literature.
- Technique and outcome of Domino Liver Transplantation from patients with Maple Syrup Urine Disease: Expanding the donor pool for Live Donor Liver Transplantation.
- Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders.
- Epidemiology and clinical course of primary biliary cholangitis in the Asia-Pacific region: a systematic review and meta-analysis.
- Immune-related adverse reactions in the hepatobiliary system: Second generation checkpoint inhibitors highlight diverse histological changes.
- Comparison of risk scores in the PSC arena.
- MicroRNA-210 promotes bile acid-induced cholestatic liver injury by targeting mixed-lineage leukemia-4 methyltransferase in mice.
- The challenges of primary biliary cholangitis: What is new and what needs to be done.
- Genetic contribution of ABCC2 to Dubin-Johnson syndrome and inherited cholestatic disorders.
- Familial low phospholipid-associated cholelithiasis resulting from an autosomal dominant ABCB4 mutation.
- The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review.
- Farnesoid X nuclear receptor agonists for the treatment of nonalcoholic steatohepatitis.
- Waiting list mortality for pediatric deceased donor liver transplantation in a Japanese living-donor-dominant program.
- Near infrared spectroscopy reveals brain hypoxia and cerebrovascular dysregulation in primary biliary cholangitis.
- ANNALS EXPRESS: A review of the clinical utility of the Enhanced Liver Fibrosis test in multiple aetiologies of Chronic Liver Disease.
- Kratom-Induced Cholestatic Liver Injury Mimicking Anti-Mitochondrial Antibody-Negative Primary Biliary Cholangitis: A Case Report and Review of Literature.
- Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2-/- mouse model of primary sclerosing cholangitis (PSC).
- Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2-/- mice.
- Association of solid-phase assays to the indirect immunofluorescence in primary biliary cholangitis diagnosis: Results of an Italian multicenter study.
- Autoimmune hepatitis in patients with human immunodeficiency virus infection: A systematic review of the published literature.
- Clinical profile and outcome of primary sclerosing cholangitis: A single-centre experience from western India.
- Risk stratification in primary sclerosing cholangitis: It's time to move on from replicating imperfection and break the glass ceiling.
- Observed or Predicted Albendazole Hepatotoxicity as an Indication for a Resection Procedure in Hepatic Hydatid Disease - A Short Series of Cases.
- Unchecked immunity: a unique case of sequential immune-related adverse events with Pembrolizumab.
- Drug Therapies for Chronic Cholestatic Liver Diseases.
- IgG4-Related Sclerosing Cholangitis: A Clinical and Imaging Review.
- Patterns of serum lipids derangements and cardiovascular risk assessment in patients with primary biliary cholangitis.
- Deficiency of canonical Wnt/β-catenin signaling in hepatic dendritic cells triggers autoimmune hepatitis.
- Application of Risk Scores in the Daily Management of Primary Biliary Cholangitis: Response to Corpechot and Chazouillères.
- Fas, FasL and Foxp3 gene expression in post-liver transplant autoimmune hepatitis patients with and without acute rejection.
- Workup and Management of Immune-Mediated Hepatobiliary Pancreatic Toxicities That Develop During Immune Checkpoint Inhibitor Treatment.
- Inflammatory Bowel Disease in Children with Elevated Serum Gamma Glutamyltransferase Levels.
- Acute liver failure.
- A National Hospital-Based Study of Hospitalized Patients With Primary Biliary Cholangitis.
- High-Throughput Immunogenetics Reveals a Lack of Physiological T Cell Clusters in Patients With Autoimmune Cytopenias.
- Overexpression of MHCII by hepatocytes in Alcoholic Hepatitis (AH) compared to Non-alcoholic Steatohepatitis (NASH) and normal controls.
- Primary Sclerosing Cholangitis in Children With Inflammatory Bowel Diseases is Associated with Milder Clinical Activity but More Frequent Subclinical Inflammation and Growth Impairment.
- Patterns and prevalence of dyslipidemia in patients with different etiologies of chronic liver disease.
- Race/Ethnicity and Insurance-Specific Disparities in In-Hospital Mortality Among Adults with Primary Biliary Cholangitis: Analysis of 2007-2014 National Inpatient Sample.
- [Meta Analysis of Risks of Cardiocerebral Vascular Events in Patients with Primary Biliary Cholangitis].
- The efficacy and adverse effects of budesonide in remission induction treatment of autoimmune hepatitis: a retrospective study.
- [No significant association between obesity and long-term outcome of coronary artery bypass grafting].
- Ursodeoxycholic acid in pregnancy ?
- EUS-guided gallbladder drainage in patients with cirrhosis: results of a multicenter retrospective study.
- Effectiveness of bezafibrate and ursodeoxycholic acid in patients with primary biliary cholangitis: a meta-analysis of randomized controlled trials.
- Acute onset of autoimmune hepatitis in children and adolescents.
- The significance of ANCA positivity in patients with inflammatory bowel disease.
- A Bile Duct-on-a-Chip with Organ-Level Functions.
- Galectin-9 in autoimmune hepatitis: Correlation between serum levels of galectin-9 and M2BPGi in patients with autoimmune hepatitis.
- Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.
- HLA-DRB1 GENE POLYMORPHISMS IN PEDIATRIC PATIENTS WITH TYPE 1 AUTOIMMUNE HEPATITIS AND TYPE 1 AUTOIMMUNE HEPATITIS OVERLAP SYNDROME WITH AUTOIMMUNE CHOLANGITIS.
- Association between serum IgG level and clinical course in primary sclerosing cholangitis.
- UPDATE OF THE BRAZILIAN SOCIETY OF HEPATOLOGY RECOMMENDATIONS FOR DIAGNOSIS AND MANAGEMENT OF AUTOIMMUNE DISEASES OF THE LIVER.
- Development of Leiomyosarcoma in a Patient Treated with Azathioprine.
- A Study of Effect of Long-term Oral Steroids on Intraocular Pressure in Children with Autoimmune Hepatitis.
- Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients.
- Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance.
- Sensory neuronopathy as a rare presentation of primary biliary cholangitis.
- Omentin, vaspin and irisin in chronic liver diseases.
- Fatigue in Primary Biliary Cholangitis: no Place for Rituximab.
- A Patient with Type 3 Autoimmune Polyglandular Syndrome who Developed Systemic Lupus Erythematosus 8 years after the Diagnosis of Autoimmune Hepatitis.
- Prediction of Transplant-Free Survival through Albumin-Bilirubin Score in Primary Biliary Cholangitis.
- Phosphatidylcholine Passes by Paracellular Transport to the Apical Side of the Polarized Biliary Tumor Cell Line Mz-ChA-1.
- Increased incidence of autoimmune hepatitis is associated with wider use of biological drugs.
- Efficacy and safety of 3-year denosumab therapy for osteoporosis in patients with autoimmune liver diseases.
- Overlap Syndrome Involving Systemic Lupus Erythematosus and Autoimmune Hepatitis in Children: A Case Report and Literature Review.
- Safety of vedolizumab in liver transplant recipients: A systematic review.
- A Brief Reflection on Continuous vs Binary Risk Indicators in Primary Biliary Cholangitis.
- Clinical Pathologic Mismatch in a TNF-α Inhibitor-Associated Drug Reaction
- Differentiating pediatric autoimmune liver diseases by quantitative magnetic resonance cholangiopancreatography.
- Foxp3⁺ Treg Cells Are Associated with Pathological Process of Autoimmune Hepatitis by Activating Methylation Modification in Autoimmune Hepatitis Patients.
- The Potential Effects of Diabetes Mellitus on Liver Fibrosis in Patients with Primary Biliary Cholangitis.
- Factors Associated With Progression and Outcomes of Early-stage Primary Biliary Cholangitis.
- Redox regulation of hepatic NLRP3 inflammasome activation and immune dysregulation in trichloroethene-mediated autoimmunity.